Unio Capital LLC Bristol Myers Squibb CO Transaction History

Unio Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $262,365 - $290,119	-5,880 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $14,664 - $17,485	-325 Reduced 5.24%	5,880 $281,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $87,768 - $113,814	-1,800 Reduced 22.49%	6,205 $323,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $40,012 - $45,131	-725 Reduced 8.3%	8,005 $497,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $41,181 - $51,328	-815 Reduced 8.54%	8,730 $483,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $5,992 - $6,898	-100 Reduced 1.04%	9,545 $604,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $578,121 - $630,300	9,645	9,645 $591,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Unio Capital LLC with notifications on news.